Literature DB >> 10496135

Clinical signs associated with brain tumors in dogs: 97 cases (1992-1997).

R S Bagley1, P R Gavin, M P Moore, G M Silver, M L Harrington, R L Connors.   

Abstract

OBJECTIVE: To determine the prevalence of various clinical signs in dogs with brain tumors.
DESIGN: Retrospective study. ANIMALS: 97 dogs with brain tumors. PROCEDURE: Medical records were reviewed for signalment, tumor type and location, and clinical signs.
RESULTS: 33 breeds were represented; Golden Retrievers were most commonly affected. Most dogs were older (median age, 9 years); 95% of dogs were > or = 5 years old. Seventy-six percent of dogs had tumors in the supratentorial region. Seizures were the most common clinical sign at initial examination, with lower prevalence for circling, ataxia, and head tilt. Meningioma was the most common tumor. CONCLUSIONS AND CLINICAL RELEVANCE: Brain tumors develop most often in dogs > or = 5 years old and are uncommon in dogs < 5 years old. Seizures are a common clinical sign, and a brain tumor should be considered in dogs that have their first seizure after they are 4 years old.

Entities:  

Mesh:

Year:  1999        PMID: 10496135

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  15 in total

1.  Evaluation of the clinical signs and computed tomographic findings in 27 dogs with intracranial space-occupying lesions (1999-2000).

Authors:  G Gandini; F Gentilini; L Cimatti; P Famigli Bergamini; M Cipone
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Clinical Risk Factors for Early Seizure Recurrence in Dogs Hospitalized for Seizure Evaluation.

Authors:  M Kwiatkowska; A Tipold; E Huenerfauth; A Pomianowski
Journal:  J Vet Intern Med       Date:  2018-02-18       Impact factor: 3.333

3.  Clinical features, diagnosis, and survival analysis of dogs with glioma.

Authors:  Roberto José-López; Rodrigo Gutierrez-Quintana; Cristian de la Fuente; Edgar G Manzanilla; Anna Suñol; Dolors Pi Castro; Sonia Añor; Daniel Sánchez-Masian; Francisco Fernández-Flores; Emanuele Ricci; Katia Marioni-Henry; Joan Mascort; Lara A Matiasek; Kaspar Matiasek; Paul M Brennan; Martí Pumarola
Journal:  J Vet Intern Med       Date:  2021-06-12       Impact factor: 3.175

Review 4.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

5.  Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy.

Authors:  A L Zwingenberger; R E Pollard; S L Taylor; R X Chen; J Nunley; M S Kent
Journal:  J Vet Intern Med       Date:  2016-05-05       Impact factor: 3.333

6.  A canine case with cystic meningioma showing miraculous reduction of the cystic lesion.

Authors:  Masae Wada; Daisuke Hasegawa; Yuji Hamamoto; Atsushi Asai; Akane Shouji; James Chambers; Kazuyuki Uchida; Michio Fujita
Journal:  J Vet Med Sci       Date:  2015-08-10       Impact factor: 1.267

7.  Long-term follow-up of surgical resection alone for primary intracranial rostrotentorial tumors in dogs: 29 cases (2002-2013).

Authors:  Anna Suñol; Joan Mascort; Cristina Font; Alicia Rami Bastante; Martí Pumarola; Alejandro Lujan Feliu-Pascual
Journal:  Open Vet J       Date:  2017-12-26

Review 8.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

9.  Retrospective analysis of seizures associated with feline infectious peritonitis in cats.

Authors:  Doris Timmann; Sigitas Cizinauskas; Ales Tomek; Marcus Doherr; Marc Vandevelde; André Jaggy
Journal:  J Feline Med Surg       Date:  2007-08-31       Impact factor: 2.015

10.  Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England.

Authors:  Imogen Schofield; David C Brodbelt; Anna R L Wilson; Stijn Niessen; David Church; Dan O'Neill
Journal:  Vet Rec       Date:  2019-09-20       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.